These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25040481)

  • 41. Spontaneous T wave alternans in a patient with Brugada syndrome--responses to intravenous administration of class I antiarrhythmic drug, glucose tolerance test, and atrial pacing.
    Nishizaki M; Fujii H; Sakurada H; Kimura A; Hiraoka M
    J Cardiovasc Electrophysiol; 2005 Feb; 16(2):217-20. PubMed ID: 15720462
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia.
    Khoury A; Marai I; Suleiman M; Blich M; Lorber A; Gepstein L; Boulos M
    Heart Rhythm; 2013 Nov; 10(11):1671-5. PubMed ID: 23954267
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Flecainide in patient with aggressive catecholaminergic polymorphic ventricular tachycardia due to novel RYR2 mutation.
    Wangüemert-Pérez F; Ruiz-Hernández PM; Campuzano O; Caballero-Dorta E; Bosch C; Brugada J; Brugada R
    Minerva Cardioangiol; 2014 Aug; 62(4):363-6. PubMed ID: 25012103
    [No Abstract]   [Full Text] [Related]  

  • 44. Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature.
    Pott C; Dechering DG; Reinke F; Muszynski A; Zellerhoff S; Bittner A; Köbe J; Wasmer K; Schulze-Bahr E; Mönnig G; Kotthoff S; Eckardt L
    Europace; 2011 Jun; 13(6):897-901. PubMed ID: 21292648
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytosolic calcium accumulation and delayed repolarization associated with ventricular arrhythmias in a guinea pig model of Andersen-Tawil syndrome.
    Radwański PB; Veeraraghavan R; Poelzing S
    Heart Rhythm; 2010 Oct; 7(10):1428-1435.e1. PubMed ID: 20380896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Flecainide acetate].
    Bordier P; Garrigue S; Clémenty J
    Ann Cardiol Angeiol (Paris); 1996 May; 45(5):263-79. PubMed ID: 8763646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A case of Andersen-Tawil syndrome presenting periodic paralysis exacerbated by acetazolamide.
    Nagamine S; Sakoda S; Koide R; Kawata A; Yuan J; Takashima H; Nakano I
    J Neurol Sci; 2014 Dec; 347(1-2):385-6. PubMed ID: 25284084
    [No Abstract]   [Full Text] [Related]  

  • 48. Inhibition of Na+ channels ameliorates arrhythmias in a drug-induced model of Andersen-Tawil syndrome.
    Radwański PB; Greer-Short A; Poelzing S
    Heart Rhythm; 2013 Feb; 10(2):255-63. PubMed ID: 23041575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype.
    Zhang L; Benson DW; Tristani-Firouzi M; Ptacek LJ; Tawil R; Schwartz PJ; George AL; Horie M; Andelfinger G; Snow GL; Fu YH; Ackerman MJ; Vincent GM
    Circulation; 2005 May; 111(21):2720-6. PubMed ID: 15911703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Case report: A Chinese child with Andersen-Tawil syndrome due to a de novo KCNJ2 mutation.
    Liu XL; Huang XJ; Luan XH; Zhou HY; Wang T; Wang JY; Shen JY; Chen SD; Tang HD; Cao L
    J Neurol Sci; 2015 May; 352(1-2):105-6. PubMed ID: 25847018
    [No Abstract]   [Full Text] [Related]  

  • 51. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and neurophysiological variability in Andersen-Tawil syndrome.
    Kokubun N; Aoki R; Nagashima T; Komagamine T; Kuroda Y; Horie M; Hirata K
    Muscle Nerve; 2019 Dec; 60(6):752-757. PubMed ID: 31509255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Direct-current cardioversion of atrial tachyarrhythmias under oral flecainide therapy.
    Leclercq JF; Bizot J; Attuel P; Coumel P
    Am J Cardiol; 1997 Sep; 80(5):645-8. PubMed ID: 9295002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
    Katritsis D; Rowland E; O'Nunain S; Shakespeare CF; Poloniecki J; Camm AJ
    Eur Heart J; 1995 Dec; 16(12):1930-5. PubMed ID: 8682029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of class III-induced proarrhythmias by flecainide in an animal model of the acquired long QT syndrome.
    Hallman K; Carlsson L
    Pharmacol Toxicol; 1995 Oct; 77(4):250-4. PubMed ID: 8577635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Torsades de pointes ventricular tachycardia induced by mosapride and flecainide in the presence of hypokalemia.
    Ohki R; Takahashi M; Mizuno O; Fujikawa H; Mitsuhashi T; Katsuki T; Ikeda U; Shimada K
    Pacing Clin Electrophysiol; 2001 Jan; 24(1):119-21. PubMed ID: 11227957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A case of acute ventricular capture threshold rise associated with flecainide acetate.
    Kang TS; Yoon YW; Park S; Hong BK; Kim D; Kwon HM; Kim HS
    Yonsei Med J; 2006 Feb; 47(1):152-4. PubMed ID: 16502500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.
    van der Werf C; Kannankeril PJ; Sacher F; Krahn AD; Viskin S; Leenhardt A; Shimizu W; Sumitomo N; Fish FA; Bhuiyan ZA; Willems AR; van der Veen MJ; Watanabe H; Laborderie J; Haïssaguerre M; Knollmann BC; Wilde AA
    J Am Coll Cardiol; 2011 May; 57(22):2244-54. PubMed ID: 21616285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quinidine in short QT syndrome: an old drug for a new disease.
    Kaufman ES
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):665-6. PubMed ID: 17521305
    [No Abstract]   [Full Text] [Related]  

  • 60. Unusual electrocardiogram findings in a preterm infant after fetal tachycardia with hydrops fetalis treated with flecainide.
    Trotter A; Kaestner M; Pohlandt F; Lang D
    Pediatr Cardiol; 2000; 21(3):259-62. PubMed ID: 10818187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.